English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Amanda Rupp | Apr 15, 2016

Study suggests few COPD patients would improve from inhaled corticosteroids

+ Technology/Innovation
Amanda Rupp | Apr 15, 2016

FDA speeds approval of AbbVie's Venclexta tablets for leukemia patients

+ Technology/Innovation
Amanda Rupp | Apr 14, 2016

BIO prepares for 2016 World Congress on Industrial Biotechnology

+ Technology/Innovation
Amanda Rupp | Apr 14, 2016

EAS Sports Nutrition line shown to improve performance

+ Technology/Innovation
Amanda Rupp | Apr 14, 2016

WHO calls for better accessibility to psoriasis treatments

+ Technology/Innovation
Amanda Rupp | Apr 14, 2016

Biogen treatments capable of serving diversity of MS patients' needs

+ Technology/Innovation
Amanda Rupp | Apr 14, 2016

Autism Speaks study reveals cost of growing adult autistic population

+ Regulatory
Vimbai Chikomo | Apr 13, 2016

Kaiser Family Foundation study shows drastic increase in out-of-pocket medical expenses

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 462
  • 463
  • 464
  • 465
  • 466
  • 467
  • 468
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily